These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
151 related items for PubMed ID: 24722152
1. Molecular mechanisms underlying oncogenic RET fusion in lung adenocarcinoma. Mizukami T, Shiraishi K, Shimada Y, Ogiwara H, Tsuta K, Ichikawa H, Sakamoto H, Kato M, Shibata T, Nakano T, Kohno T. J Thorac Oncol; 2014 May; 9(5):622-30. PubMed ID: 24722152 [Abstract] [Full Text] [Related]
2. Molecular Process Producing Oncogene Fusion in Lung Cancer Cells by Illegitimate Repair of DNA Double-Strand Breaks. Seki Y, Mizukami T, Kohno T. Biomolecules; 2015 Sep 30; 5(4):2464-76. PubMed ID: 26437441 [Abstract] [Full Text] [Related]
5. Diagnostic method for the detection of KIF5B-RET transformation in lung adenocarcinoma. Go H, Jung YJ, Kang HW, Park IK, Kang CH, Lee JW, Ju YS, Seo JS, Chung DH, Kim YT. Lung Cancer; 2013 Oct 30; 82(1):44-50. PubMed ID: 23932363 [Abstract] [Full Text] [Related]
12. The RET fusion gene and its correlation with demographic and clinicopathological features of non-small cell lung cancer: a meta-analysis. Lin C, Wang S, Xie W, Chang J, Gan Y. Cancer Biol Ther; 2015 Dec 12; 16(7):1019-28. PubMed ID: 25975578 [Abstract] [Full Text] [Related]
13. RET Fusion Lung Carcinoma: Response to Therapy and Clinical Features in a Case Series of 14 Patients. Sarfaty M, Moore A, Neiman V, Dudnik E, Ilouze M, Gottfried M, Katznelson R, Nechushtan H, Sorotsky HG, Paz K, Katz A, Saute M, Wolner M, Moskovitz M, Miller V, Elvin J, Lipson D, Ali S, Gutman LS, Dvir A, Gordon N, Peled N. Clin Lung Cancer; 2017 Jul 12; 18(4):e223-e232. PubMed ID: 28082048 [Abstract] [Full Text] [Related]
14. Analysis of major known driver mutations and prognosis in resected adenosquamous lung carcinomas. Wang R, Pan Y, Li C, Zhang H, Garfield D, Li Y, Ye T, Hu H, Luo X, Li H, Zhang Y, Zhang J, Zhou X, Shen L, Pao W, Sun Y, Chen H. J Thorac Oncol; 2014 Jun 12; 9(6):760-8. PubMed ID: 24481316 [Abstract] [Full Text] [Related]
17. Identification and Validation of Noncanonical RET Fusions in Non-Small-Cell Lung Cancer through DNA and RNA Sequencing. Xiang C, Guo L, Zhao R, Teng H, Wang Y, Xiong L, Han Y. J Mol Diagn; 2022 Apr 12; 24(4):374-385. PubMed ID: 35063667 [Abstract] [Full Text] [Related]
18. Identification of a novel partner gene, KIAA1217, fused to RET: Functional characterization and inhibitor sensitivity of two isoforms in lung adenocarcinoma. Lee MS, Kim RN, I H, Oh DY, Song JY, Noh KW, Kim YJ, Yang JW, Lira ME, Lee CH, Lee MK, Kim YD, Mao M, Han J, Kim J, Choi YL. Oncotarget; 2016 Jun 14; 7(24):36101-36114. PubMed ID: 27150058 [Abstract] [Full Text] [Related]
19. A single-tube multiplexed assay for detecting ALK, ROS1, and RET fusions in lung cancer. Lira ME, Choi YL, Lim SM, Deng S, Huang D, Ozeck M, Han J, Jeong JY, Shim HS, Cho BC, Kim J, Ahn MJ, Mao M. J Mol Diagn; 2014 Mar 14; 16(2):229-43. PubMed ID: 24418728 [Abstract] [Full Text] [Related]